Global X HLTH Care Cov CallHYLGETF

13F holders, Q3 2024 (September 30)
4holders
1new positions
1sold out
$26.25avg. 13F price*

At the end of Q3 2024, 4 institutions reported holding Global X HLTH Care Cov Call (HYLG) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Cambridge Investment Research Advisors, Inc. ($236K), Royal Bank of Canada ($45K) and National Bank of Canada ($21K).

Company
Global X HLTH Care Cov Call
CUSIP
37960A750
Latest filing quarter
Q4 2024

History

Number of 13F holders

01234 Q1 2024: 3Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 3Q4 2024

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$708
Exits1$92

All 13F filers, Q2 2024 → Q3 2024: 1,581 shares bought and 3 shares sold, net +1,578 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

Cambridge Investment Research Advisors, Inc. 0.00% Add +3.9% 8,987 $236K
Royal Bank of Canada 0.00% Add +243.6% 1,718 $45K
National Bank of Canada 0.00% No change 789 $21K
UBS Group AG 0.00% New 27 $708

"% of holder's portfolio" is HYLG's weight in each manager's 13F, not the share of Global X HLTH Care Cov Call the manager owns.